Mexico - Delayed Quote MXN
Regeneron Pharmaceuticals, Inc. (REGN.MX)
As of October 18 at 1:58 PM CST. Market Open.
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Assets
33,080,200.00
29,214,500.00
25,434,800.00
17,163,300.00
--
Total Liabilities Net Minority Interest
7,107,100.00
6,550,500.00
6,666,000.00
6,138,000.00
--
Total Equity Gross Minority Interest
25,973,100.00
22,664,000.00
18,768,800.00
11,025,300.00
--
Total Capitalization
27,956,000.00
24,645,400.00
20,748,800.00
13,003,800.00
--
Common Stock Equity
25,973,100.00
22,664,000.00
18,768,800.00
11,025,300.00
--
Capital Lease Obligations
720,000.00
720,000.00
719,700.00
717,200.00
--
Net Tangible Assets
24,934,500.00
21,748,500.00
18,762,100.00
11,025,300.00
--
Working Capital
16,055,800.00
12,742,800.00
10,082,400.00
7,081,700.00
--
Invested Capital
27,956,000.00
24,645,400.00
20,748,800.00
13,003,800.00
--
Tangible Book Value
24,934,500.00
21,748,500.00
18,762,100.00
11,025,300.00
--
Total Debt
2,702,900.00
2,701,400.00
2,699,700.00
2,695,700.00
--
Share Issued
134,918.15
132,200.00
128,067.73
123,382.43
--
Ordinary Shares Number
109,418.15
109,600.00
108,674.77
106,950.91
--
Treasury Shares Number
25,500.00
22,600.00
19,392.96
16,431.52
--
12/31/2019 - 1/8/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade